Deka Bank Deutsche Girozentrale Poseida Therapeutics, Inc. Transaction History
Deka Bank Deutsche Girozentrale
- $51 Billion
- Q1 2025
A detailed history of Deka Bank Deutsche Girozentrale transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 100,000 shares of PSTX stock, worth $950,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100,000
Previous 100,000
-0.0%
Holding current value
$950,000
Previous $913,000
66.27%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PSTX
# of Institutions
10Shares Held
6.52MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY4.91MShares$46.6 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA933KShares$8.86 Million0.03% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL299KShares$2.84 Million0.0% of portfolio
-
Strs Ohio124KShares$1.18 Million0.0% of portfolio
-
Cigogne Management Sa Luxembourg, N4120KShares$1.14 Million0.68% of portfolio
About Poseida Therapeutics, Inc.
- Ticker PSTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 85,775,600
- Market Cap $815M
- Description
- Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...